nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Dactinomycin—uterine cancer	0.472	1	CbGbCtD
Cefadroxil—Genital candidiasis—Progesterone—uterine cancer	0.0282	0.057	CcSEcCtD
Cefadroxil—Infertility—Progesterone—uterine cancer	0.0236	0.0477	CcSEcCtD
Cefadroxil—Pruritus genital—Progesterone—uterine cancer	0.0148	0.0298	CcSEcCtD
Cefadroxil—Digestion impaired—Progesterone—uterine cancer	0.00923	0.0186	CcSEcCtD
Cefadroxil—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.00836	0.0169	CcSEcCtD
Cefadroxil—Cholestasis—Progesterone—uterine cancer	0.00812	0.0164	CcSEcCtD
Cefadroxil—Vaginal inflammation—Progesterone—uterine cancer	0.00617	0.0124	CcSEcCtD
Cefadroxil—Vaginal infection—Progesterone—uterine cancer	0.00582	0.0117	CcSEcCtD
Cefadroxil—Vaginal inflammation—Medroxyprogesterone Acetate—uterine cancer	0.00559	0.0113	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Medroxyprogesterone Acetate—uterine cancer	0.00559	0.0113	CcSEcCtD
Cefadroxil—Nephropathy toxic—Etoposide—uterine cancer	0.00549	0.0111	CcSEcCtD
Cefadroxil—Vaginal infection—Medroxyprogesterone Acetate—uterine cancer	0.00528	0.0106	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Progesterone—uterine cancer	0.00512	0.0103	CcSEcCtD
Cefadroxil—Swelling—Progesterone—uterine cancer	0.00507	0.0102	CcSEcCtD
Cefadroxil—Hepatic failure—Progesterone—uterine cancer	0.00498	0.0101	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Medroxyprogesterone Acetate—uterine cancer	0.00466	0.00941	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00464	0.00937	CcSEcCtD
Cefadroxil—Swelling—Medroxyprogesterone Acetate—uterine cancer	0.0046	0.00928	CcSEcCtD
Cefadroxil—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00451	0.00911	CcSEcCtD
Cefadroxil—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00449	0.00907	CcSEcCtD
Cefadroxil—Prothrombin level increased—Epirubicin—uterine cancer	0.00431	0.0087	CcSEcCtD
Cefadroxil—Aplastic anaemia—Dactinomycin—uterine cancer	0.00409	0.00826	CcSEcCtD
Cefadroxil—Cramp muscle—Progesterone—uterine cancer	0.00403	0.00813	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00403	0.00813	CcSEcCtD
Cefadroxil—Prothrombin level increased—Doxorubicin—uterine cancer	0.00399	0.00805	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00395	0.00797	CcSEcCtD
Cefadroxil—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.0038	0.00767	CcSEcCtD
Cefadroxil—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00365	0.00737	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.00722	CcSEcCtD
Cefadroxil—Hepatic failure—Dactinomycin—uterine cancer	0.00352	0.0071	CcSEcCtD
Cefadroxil—Lactic dehydrogenase activity increased—Epirubicin—uterine cancer	0.00346	0.00697	CcSEcCtD
Cefadroxil—Drowsiness—Progesterone—uterine cancer	0.00345	0.00696	CcSEcCtD
Cefadroxil—Body temperature increased—Carboplatin—uterine cancer	0.00331	0.00668	CcSEcCtD
Cefadroxil—Lactic dehydrogenase activity increased—Doxorubicin—uterine cancer	0.0032	0.00645	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Etoposide—uterine cancer	0.00316	0.00637	CcSEcCtD
Cefadroxil—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00313	0.00631	CcSEcCtD
Cefadroxil—Haemoglobin—Progesterone—uterine cancer	0.00311	0.00628	CcSEcCtD
Cefadroxil—Haemorrhage—Progesterone—uterine cancer	0.0031	0.00625	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Epirubicin—uterine cancer	0.00304	0.00614	CcSEcCtD
Cefadroxil—Erythema multiforme—Progesterone—uterine cancer	0.00293	0.00591	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00285	0.00575	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00285	0.00575	CcSEcCtD
Cefadroxil—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00282	0.00569	CcSEcCtD
Cefadroxil—Blood lactate dehydrogenase increased—Doxorubicin—uterine cancer	0.00282	0.00568	CcSEcCtD
Cefadroxil—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00281	0.00566	CcSEcCtD
Cefadroxil—SLC15A1—epithelium—uterine cancer	0.00267	0.0836	CbGeAlD
Cefadroxil—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.00535	CcSEcCtD
Cefadroxil—Tension—Progesterone—uterine cancer	0.00265	0.00534	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.00263	0.00531	CcSEcCtD
Cefadroxil—Nervousness—Progesterone—uterine cancer	0.00262	0.00528	CcSEcCtD
Cefadroxil—Pancytopenia—Dactinomycin—uterine cancer	0.0026	0.00524	CcSEcCtD
Cefadroxil—Swelling—Etoposide—uterine cancer	0.0026	0.00524	CcSEcCtD
Cefadroxil—Muscle spasms—Progesterone—uterine cancer	0.00259	0.00523	CcSEcCtD
Cefadroxil—Neutropenia—Dactinomycin—uterine cancer	0.00256	0.00516	CcSEcCtD
Cefadroxil—SLC15A1—renal system—uterine cancer	0.00247	0.0775	CbGeAlD
Cefadroxil—Angioedema—Progesterone—uterine cancer	0.00246	0.00497	CcSEcCtD
Cefadroxil—Vertigo—Progesterone—uterine cancer	0.00242	0.00489	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00242	0.00488	CcSEcCtD
Cefadroxil—Tension—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.00484	CcSEcCtD
Cefadroxil—SLC15A1—endometrium—uterine cancer	0.00239	0.075	CbGeAlD
Cefadroxil—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00479	CcSEcCtD
Cefadroxil—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00474	CcSEcCtD
Cefadroxil—Convulsion—Progesterone—uterine cancer	0.00234	0.00471	CcSEcCtD
Cefadroxil—SLC15A1—mammalian vulva—uterine cancer	0.00231	0.0725	CbGeAlD
Cefadroxil—Arthralgia—Progesterone—uterine cancer	0.0023	0.00463	CcSEcCtD
Cefadroxil—Agranulocytosis—Dactinomycin—uterine cancer	0.00228	0.00459	CcSEcCtD
Cefadroxil—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.0045	CcSEcCtD
Cefadroxil—Anaphylactic shock—Progesterone—uterine cancer	0.0022	0.00444	CcSEcCtD
Cefadroxil—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00443	CcSEcCtD
Cefadroxil—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00427	CcSEcCtD
Cefadroxil—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.0042	CcSEcCtD
Cefadroxil—Erythema multiforme—Dactinomycin—uterine cancer	0.00207	0.00418	CcSEcCtD
Cefadroxil—Cramp muscle—Etoposide—uterine cancer	0.00206	0.00416	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00206	0.00416	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00202	0.00408	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Progesterone—uterine cancer	0.002	0.00404	CcSEcCtD
Cefadroxil—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00402	CcSEcCtD
Cefadroxil—Somnolence—Progesterone—uterine cancer	0.00196	0.00395	CcSEcCtD
Cefadroxil—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00195	0.00394	CcSEcCtD
Cefadroxil—Dyspepsia—Progesterone—uterine cancer	0.00194	0.00391	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Progesterone—uterine cancer	0.0019	0.00383	CcSEcCtD
Cefadroxil—Pancytopenia—Etoposide—uterine cancer	0.00188	0.00379	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Epirubicin—uterine cancer	0.00187	0.00377	CcSEcCtD
Cefadroxil—Creatinine increased—Epirubicin—uterine cancer	0.00186	0.00375	CcSEcCtD
Cefadroxil—Neutropenia—Etoposide—uterine cancer	0.00185	0.00373	CcSEcCtD
Cefadroxil—SLC22A5—myometrium—uterine cancer	0.00185	0.0579	CbGeAlD
Cefadroxil—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00367	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Progesterone—uterine cancer	0.0018	0.00363	CcSEcCtD
Cefadroxil—SLC15A1—vagina—uterine cancer	0.00179	0.0562	CbGeAlD
Cefadroxil—SLC22A8—renal system—uterine cancer	0.00178	0.0558	CbGeAlD
Cefadroxil—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00358	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.00177	0.00357	CcSEcCtD
Cefadroxil—Vaginal inflammation—Epirubicin—uterine cancer	0.00177	0.00357	CcSEcCtD
Cefadroxil—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00354	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00175	0.00353	CcSEcCtD
Cefadroxil—Urticaria—Progesterone—uterine cancer	0.00175	0.00353	CcSEcCtD
Cefadroxil—Body temperature increased—Progesterone—uterine cancer	0.00174	0.00351	CcSEcCtD
Cefadroxil—Abdominal pain—Progesterone—uterine cancer	0.00174	0.00351	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—uterine cancer	0.00173	0.00349	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00347	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—uterine cancer	0.00172	0.00347	CcSEcCtD
Cefadroxil—Blood urea increased—Epirubicin—uterine cancer	0.00167	0.00337	CcSEcCtD
Cefadroxil—Vaginal infection—Epirubicin—uterine cancer	0.00167	0.00337	CcSEcCtD
Cefadroxil—Aplastic anaemia—Epirubicin—uterine cancer	0.00166	0.00335	CcSEcCtD
Cefadroxil—SLC15A2—uterine cervix—uterine cancer	0.00165	0.0518	CbGeAlD
Cefadroxil—Agranulocytosis—Etoposide—uterine cancer	0.00165	0.00332	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—uterine cancer	0.00164	0.0033	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.00164	0.0033	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00329	CcSEcCtD
Cefadroxil—Hypersensitivity—Progesterone—uterine cancer	0.00162	0.00327	CcSEcCtD
Cefadroxil—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.0032	CcSEcCtD
Cefadroxil—Asthenia—Progesterone—uterine cancer	0.00158	0.00319	CcSEcCtD
Cefadroxil—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00318	CcSEcCtD
Cefadroxil—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00318	CcSEcCtD
Cefadroxil—Pruritus—Progesterone—uterine cancer	0.00156	0.00314	CcSEcCtD
Cefadroxil—SLC15A2—renal system—uterine cancer	0.00155	0.0485	CbGeAlD
Cefadroxil—Vaginal infection—Doxorubicin—uterine cancer	0.00154	0.00312	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—uterine cancer	0.00154	0.00312	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—uterine cancer	0.00154	0.0031	CcSEcCtD
Cefadroxil—Thrombocytopenia—Dactinomycin—uterine cancer	0.00152	0.00307	CcSEcCtD
Cefadroxil—Diarrhoea—Progesterone—uterine cancer	0.00151	0.00304	CcSEcCtD
Cefadroxil—Erythema multiforme—Etoposide—uterine cancer	0.0015	0.00302	CcSEcCtD
Cefadroxil—SLC15A2—endometrium—uterine cancer	0.00149	0.0469	CbGeAlD
Cefadroxil—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.00148	0.00298	CcSEcCtD
Cefadroxil—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00296	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Epirubicin—uterine cancer	0.00147	0.00296	CcSEcCtD
Cefadroxil—Dizziness—Progesterone—uterine cancer	0.00146	0.00294	CcSEcCtD
Cefadroxil—SLC22A5—uterine cervix—uterine cancer	0.00144	0.0451	CbGeAlD
Cefadroxil—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00289	CcSEcCtD
Cefadroxil—Hepatic failure—Epirubicin—uterine cancer	0.00143	0.00288	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00142	0.00286	CcSEcCtD
Cefadroxil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00285	CcSEcCtD
Cefadroxil—Vomiting—Progesterone—uterine cancer	0.0014	0.00282	CcSEcCtD
Cefadroxil—Rash—Progesterone—uterine cancer	0.00139	0.0028	CcSEcCtD
Cefadroxil—Dermatitis—Progesterone—uterine cancer	0.00139	0.0028	CcSEcCtD
Cefadroxil—Headache—Progesterone—uterine cancer	0.00138	0.00278	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.00137	0.00276	CcSEcCtD
Cefadroxil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00275	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—uterine cancer	0.00136	0.00274	CcSEcCtD
Cefadroxil—SLC22A5—renal system—uterine cancer	0.00134	0.0422	CbGeAlD
Cefadroxil—Muscle spasms—Etoposide—uterine cancer	0.00133	0.00268	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—uterine cancer	0.00132	0.00267	CcSEcCtD
Cefadroxil—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00266	CcSEcCtD
Cefadroxil—Nausea—Progesterone—uterine cancer	0.00131	0.00264	CcSEcCtD
Cefadroxil—SLC22A5—endometrium—uterine cancer	0.0013	0.0408	CbGeAlD
Cefadroxil—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00127	0.00257	CcSEcCtD
Cefadroxil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00256	CcSEcCtD
Cefadroxil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00254	CcSEcCtD
Cefadroxil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00253	CcSEcCtD
Cefadroxil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00252	CcSEcCtD
Cefadroxil—Vertigo—Etoposide—uterine cancer	0.00124	0.0025	CcSEcCtD
Cefadroxil—SLC15A2—female reproductive system—uterine cancer	0.00124	0.0388	CbGeAlD
Cefadroxil—Abdominal pain—Dactinomycin—uterine cancer	0.00123	0.00248	CcSEcCtD
Cefadroxil—Body temperature increased—Dactinomycin—uterine cancer	0.00123	0.00248	CcSEcCtD
Cefadroxil—Blood creatinine increased—Epirubicin—uterine cancer	0.0012	0.00243	CcSEcCtD
Cefadroxil—Convulsion—Etoposide—uterine cancer	0.00119	0.00241	CcSEcCtD
Cefadroxil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00239	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00116	0.00233	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00116	0.00233	CcSEcCtD
Cefadroxil—Hypersensitivity—Dactinomycin—uterine cancer	0.00115	0.00231	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00113	0.00228	CcSEcCtD
Cefadroxil—SLC15A2—female gonad—uterine cancer	0.00113	0.0353	CbGeAlD
Cefadroxil—Anaphylactic shock—Etoposide—uterine cancer	0.00113	0.00227	CcSEcCtD
Cefadroxil—SLC15A2—vagina—uterine cancer	0.00112	0.0351	CbGeAlD
Cefadroxil—Asthenia—Dactinomycin—uterine cancer	0.00112	0.00225	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—uterine cancer	0.00111	0.00225	CcSEcCtD
Cefadroxil—Thrombocytopenia—Etoposide—uterine cancer	0.0011	0.00222	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—uterine cancer	0.0011	0.00222	CcSEcCtD
Cefadroxil—SLC22A5—female reproductive system—uterine cancer	0.00108	0.0338	CbGeAlD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00107	0.00216	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00107	0.00216	CcSEcCtD
Cefadroxil—Diarrhoea—Dactinomycin—uterine cancer	0.00106	0.00215	CcSEcCtD
Cefadroxil—Pancytopenia—Epirubicin—uterine cancer	0.00105	0.00213	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00105	0.00211	CcSEcCtD
Cefadroxil—Neutropenia—Epirubicin—uterine cancer	0.00104	0.00209	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—uterine cancer	0.00102	0.00205	CcSEcCtD
Cefadroxil—Somnolence—Etoposide—uterine cancer	0.001	0.00202	CcSEcCtD
Cefadroxil—Drowsiness—Epirubicin—uterine cancer	0.000989	0.002	CcSEcCtD
Cefadroxil—Vomiting—Dactinomycin—uterine cancer	0.000989	0.002	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000981	0.00198	CcSEcCtD
Cefadroxil—Rash—Dactinomycin—uterine cancer	0.000981	0.00198	CcSEcCtD
Cefadroxil—SLC22A5—female gonad—uterine cancer	0.00098	0.0307	CbGeAlD
Cefadroxil—Pancytopenia—Doxorubicin—uterine cancer	0.000975	0.00197	CcSEcCtD
Cefadroxil—SLC22A5—vagina—uterine cancer	0.000974	0.0305	CbGeAlD
Cefadroxil—Gastrointestinal disorder—Etoposide—uterine cancer	0.000972	0.00196	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—uterine cancer	0.00096	0.00194	CcSEcCtD
Cefadroxil—Nausea—Dactinomycin—uterine cancer	0.000924	0.00186	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—uterine cancer	0.000923	0.00186	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Etoposide—uterine cancer	0.00092	0.00186	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—uterine cancer	0.000915	0.00185	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000908	0.00183	CcSEcCtD
Cefadroxil—Urticaria—Etoposide—uterine cancer	0.000894	0.0018	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—uterine cancer	0.000893	0.0018	CcSEcCtD
Cefadroxil—Body temperature increased—Etoposide—uterine cancer	0.00089	0.0018	CcSEcCtD
Cefadroxil—Abdominal pain—Etoposide—uterine cancer	0.00089	0.0018	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—uterine cancer	0.000888	0.00179	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—uterine cancer	0.000854	0.00172	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—uterine cancer	0.00084	0.00169	CcSEcCtD
Cefadroxil—Hypersensitivity—Etoposide—uterine cancer	0.000829	0.00167	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—uterine cancer	0.000826	0.00167	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—uterine cancer	0.000822	0.00166	CcSEcCtD
Cefadroxil—Asthenia—Etoposide—uterine cancer	0.000808	0.00163	CcSEcCtD
Cefadroxil—Pruritus—Etoposide—uterine cancer	0.000796	0.00161	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—uterine cancer	0.000777	0.00157	CcSEcCtD
Cefadroxil—Diarrhoea—Etoposide—uterine cancer	0.00077	0.00155	CcSEcCtD
Cefadroxil—Tension—Epirubicin—uterine cancer	0.000759	0.00153	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—uterine cancer	0.000751	0.00151	CcSEcCtD
Cefadroxil—Dizziness—Etoposide—uterine cancer	0.000744	0.0015	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—uterine cancer	0.000743	0.0015	CcSEcCtD
Cefadroxil—SLC15A2—lymph node—uterine cancer	0.000724	0.0227	CbGeAlD
Cefadroxil—Vomiting—Etoposide—uterine cancer	0.000716	0.00144	CcSEcCtD
Cefadroxil—Rash—Etoposide—uterine cancer	0.00071	0.00143	CcSEcCtD
Cefadroxil—Dermatitis—Etoposide—uterine cancer	0.000709	0.00143	CcSEcCtD
Cefadroxil—Headache—Etoposide—uterine cancer	0.000705	0.00142	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—uterine cancer	0.000702	0.00142	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—uterine cancer	0.000695	0.0014	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—uterine cancer	0.000695	0.0014	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—uterine cancer	0.000688	0.00139	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—uterine cancer	0.00067	0.00135	CcSEcCtD
Cefadroxil—Nausea—Etoposide—uterine cancer	0.000669	0.00135	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—uterine cancer	0.000658	0.00133	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—uterine cancer	0.000643	0.0013	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—uterine cancer	0.000631	0.00127	CcSEcCtD
Cefadroxil—SLC22A5—lymph node—uterine cancer	0.00063	0.0197	CbGeAlD
Cefadroxil—Convulsion—Doxorubicin—uterine cancer	0.00062	0.00125	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—uterine cancer	0.000618	0.00125	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—uterine cancer	0.000609	0.00123	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—uterine cancer	0.000584	0.00118	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000575	0.00116	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—uterine cancer	0.000572	0.00115	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—uterine cancer	0.000561	0.00113	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—uterine cancer	0.000555	0.00112	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000545	0.0011	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000532	0.00107	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—uterine cancer	0.000519	0.00105	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—uterine cancer	0.000516	0.00104	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—uterine cancer	0.000514	0.00104	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000504	0.00102	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—uterine cancer	0.000501	0.00101	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—uterine cancer	0.000499	0.00101	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—uterine cancer	0.000499	0.00101	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000477	0.000963	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—uterine cancer	0.000465	0.000938	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—uterine cancer	0.000464	0.000936	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—uterine cancer	0.000462	0.000931	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—uterine cancer	0.000462	0.000931	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—uterine cancer	0.000453	0.000913	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—uterine cancer	0.000446	0.000901	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—uterine cancer	0.000432	0.000871	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—uterine cancer	0.00043	0.000868	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—uterine cancer	0.000419	0.000845	CcSEcCtD
Cefadroxil—Dizziness—Epirubicin—uterine cancer	0.000417	0.000842	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—uterine cancer	0.000413	0.000833	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—uterine cancer	0.000401	0.000809	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—uterine cancer	0.000399	0.000806	CcSEcCtD
Cefadroxil—Rash—Epirubicin—uterine cancer	0.000398	0.000803	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—uterine cancer	0.000397	0.000802	CcSEcCtD
Cefadroxil—Headache—Epirubicin—uterine cancer	0.000395	0.000798	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—uterine cancer	0.000386	0.000779	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—uterine cancer	0.000375	0.000756	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—uterine cancer	0.000371	0.000749	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—uterine cancer	0.000368	0.000743	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—uterine cancer	0.000368	0.000742	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—uterine cancer	0.000366	0.000738	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—uterine cancer	0.000347	0.0007	CcSEcCtD
